UniQure: Controversy Abounds As Stock Price Halves On FDA News

UniQure shares soared on positive AMT-130 Huntington's disease data, but plunged after the FDA reversed its stance on ...

Neglected cemetery holds historic ties to former Insane Asylum of Arizona

A fenced-in parcel of dirt and grass in Phoenix is the final resting place of many patients from the former Insane Asylum of ...
Fierce Biotech

uniQure's ballyhooed gene therapy for Huntington's hits FDA roadblock

The FDA is said to be making a U-turn on uniQure’s one-time gene therapy candidate for Huntington’s disease despite the ...
Hosted on MSN

uniQure Faces FDA Setback on Huntington’s Therapy

Despite this setback, uniQure is committed to working with the FDA and other regulatory bodies to find a path forward for AMT-130’s approval, emphasizing the therapy’s potential benefits for patients ...
STAT

UniQure’s FDA submission for its Huntington’s disease therapy thrown into question

In a major setback, Uniqure said that the timing of when it can file its Huntington's treatment for FDA approval "is now unclear." ...

UniQure shares plummet as FDA says inadequate clinical data for Huntington's therapy

UniQure said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy for Huntington's disease may be adequate for a marketing application, ...

Huntington’s Hub to open Saturday

HUNTINGTON, W.Va. (WSAZ) - Huntington’s new low-barrier overnight shelter is set to open Saturday, Nov. 1. The Hub, located ...